Literature DB >> 16874117

Mood disorders in intellectual disability.

Anne D Hurley1.   

Abstract

PURPOSE OF REVIEW: This article examines reviews and research on the diagnosis and treatment of mood disorders in people with intellectual disability published from September 2004 to December 2005. RECENT
FINDINGS: Patients with intellectual disability have limitations in verbal ability, and with increasing levels of disability may have an atypical clinical presentation. Thus, methods to diagnose mood disorders were a major research focus. Informant-rating scales and two self-report instruments provided data on thought patterns, aberrant behavior, appetite, and suicidality. Behavioral symptoms such as aggression were frequently associated with mood disorders. Pharmacotherapy and electroconvulsive therapy were found to be effective treatments. Mood disorders were frequently identified in people with intellectual disability, although suicide was still quite rare.
SUMMARY: Patients with milder levels of disability can use self-report measures and can be diagnosed using standard criteria with little modification. For those with more severe disability, diagnosis is challenging and often requires the use of residual categories. Atypical clinical presentation, including maladaptive behaviors, lent support for 'behavioral equivalent' substitutes of standard criteria. Typical pharmacological agents were effective for depression and electroconvulsive therapy for treatment-resistant bipolar disorder.

Entities:  

Mesh:

Year:  2006        PMID: 16874117     DOI: 10.1097/01.yco.0000238471.84206.0a

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  7 in total

1.  Test of treatment in psychiatric practice.

Authors:  Feras Ali Mustafa
Journal:  Psychopharmacol Bull       Date:  2011

2.  Cereblon Maintains Synaptic and Cognitive Function by Regulating BK Channel.

Authors:  Tae-Yong Choi; Seung-Hyun Lee; Yoon-Jung Kim; Jae Ryul Bae; Kwang Min Lee; Youhwa Jo; Soo-Jeong Kim; A-Ram Lee; Sekyu Choi; La-Mee Choi; Sunhoe Bang; Mi-Ryoung Song; Jongkyeong Chung; Kyung Jin Lee; Sung Hyun Kim; Chul-Seung Park; Se-Young Choi
Journal:  J Neurosci       Date:  2018-03-12       Impact factor: 6.167

Review 3.  Diagnosis and treatment of mood disorders in adults with developmental disabilities.

Authors:  Diana J Antonacci; Nadir Attiah
Journal:  Psychiatr Q       Date:  2008-08-23

4.  A Case of Treatment Resistant Depression and Alcohol Abuse in a Person with Mental Retardation: Response to Aripiprazole and Fluvoxamine Therapy upon Consideration of a Bipolar Diathesis after Repetitive Failure to Respond to Multiple Antidepressant Trials.

Authors:  Michele Fornaro; Giovanni Ciampa; Nicola Mosti; Alessandra Del Carlo; Giuseppe Ceraudo; Salvatore Colicchio
Journal:  Case Rep Med       Date:  2011-01-17

5.  Oligophrenin-1 moderates behavioral responses to stress by regulating parvalbumin interneuron activity in the medial prefrontal cortex.

Authors:  Minghui Wang; Nicholas B Gallo; Yilin Tai; Bo Li; Linda Van Aelst
Journal:  Neuron       Date:  2021-04-07       Impact factor: 18.688

6.  A Blind Spot? Screening for Mild Intellectual Disability and Borderline Intellectual Functioning in Admitted Psychiatric Patients: Prevalence and Associations with Coercive Measures.

Authors:  Jeanet Grietje Nieuwenhuis; Eric Onno Noorthoorn; Henk Llewellyn Inge Nijman; Paul Naarding; Cornelis Lambert Mulder
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

7.  Looking beyond lesions for causes of neuropsychological impairment in epilepsy.

Authors:  Genevieve Rayner; Chris Tailby; Graeme Jackson; Sarah Wilson
Journal:  Neurology       Date:  2019-01-11       Impact factor: 9.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.